Navixen Plus (Eprosartan, Hydrochlorothiazide)

Eprosartan hydrochlorothiazide, the active ingredient in Navixen Plus, is an Angiotensin II receptor blocker and thiazide diuretic presented as an oral tablet for oral use. It is indicated for the treatment of hypertension in adults, helping to lower elevated blood pressure by targeting two complementary physiological pathways.

GNH USA supplies Navixen Plus as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring quality manufacturing and reliable distribution across global markets while providing comprehensive support for product registration and logistics.

Navixen Plus, containing eprosartan hydrochlorothiazide, is used to manage hypertension, a condition characterized by elevated arterial pressure.

Essential hypertension: lowers systolic and diastolic blood pressure. Secondary hypertension: assists in controlling blood pressure when caused by other underlying conditions. Hypertensive patients at cardiovascular risk: contributes to risk reduction when combined with lifestyle measures.

Common Side Effects: - Dizziness or light‑headedness. - Headache. - Fatigue or weakness. - Increased urinary frequency. - Electrolyte disturbances such as low potassium. - Dry mouth.

Serious or Rare Side Effects: - Severe allergic reaction (rash, swelling, difficulty breathing). - Acute kidney injury or worsening renal function. - Severe dehydration or electrolyte imbalance. - Pancreatitis. - Blood disorders such as leukopenia or thrombocytopenia. - Marked hypotension leading to fainting.

Before initiating therapy, consider the following precautions: - Monitor electrolytes: check potassium and sodium levels regularly. - Assess renal function: evaluate kidney function before and during treatment. - Contraindicated in pregnancy: avoid use in pregnant women (Category D). - Caution with concomitant NSAIDs: may reduce antihypertensive effect. - Limit use in patients with gout: thiazide component can increase uric acid levels. - Store at ambient temperature: keep below 25°C in the original pack, protect from moisture.

Navixen Plus may interact with several medicines; awareness of these interactions helps maintain safety.

Major Interactions (Avoid): - Aliskiren: combined use may increase risk of renal impairment. - Potassium‑sparing diuretics or supplements: risk of hyperkalemia. - Lithium: thiazide component may raise lithium concentrations.

Moderate Interactions (Monitor Closely): - ACE inhibitors or other ARBs: additive blood‑pressure lowering, monitor for hypotension. - NSAIDs: may blunt diuretic effect and reduce blood‑pressure control. - Beta‑blockers: may enhance antihypertensive effect, requiring dose adjustment.